Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.
Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 15 different industry categories.
Among tracked funding rounds, ACELYRIN received $300.0M in a Series C round. Samsara BioCapital's total known invested capital is $12.1B.
Samsara BioCapital's average investment size is $113.4M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include A2 Biotherapeutics, Surrozen, Ottimo Pharma, Enara Bio, ImmunOs Therapeutics. These companies were founded in 2020 or later.